Q2 2020 Holdings
Filed 2020-08-14 | 57 holdings | $385.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Abbvie Inc(ABBV) | COM | 00287Y109 | $151.7M | 1,545,400 | 39.4% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $40.2M | 2,474,599 | 10.4% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $36.1M | 1,076,900 | 9.4% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $33.3M | 404,900 | 8.6% |
| Avantor Inc(AVTR) | COM | 05352A100 | $27.4M | 1,612,000 | 7.1% |
| Coherus Biosciences Inc(CHRS) | COM | 19249H103 | $18.3M | 1,023,500 | 4.7% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $17.6M | 118,900 | 4.6% |
| Alector Inc(ALEC) | COM | 014442107 | $16.8M | 686,400 | 4.4% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $14.6M | 589,000 | 3.8% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $14.4M | 1,438,000 | 3.7% |
| Anika Therapeutics Inc(ANIK) | COM | 035255108 | $13.7M | 362,490 | 3.6% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $82.4K | 132,100 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $80.8K | 1,104,500 | 0.0% |
| Baxter Intl Inc(BAX) | COM | 071813109 | $69.0K | 800,900 | 0.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $67.7K | 1,911,300 | 0.0% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $64.0K | 2,694,070 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $57.0K | 507,700 | 0.0% |
| Hologic Inc(HOLX) | COM | 436440101 | $46.6K | 817,200 | 0.0% |
| Seattle Genetics Inc | COM | 812578102 | $42.6K | 250,900 | 0.0% |
| Momenta Pharmaceuticals Inc(MNTA) | COM | 60877T100 | $38.3K | 1,150,000 | 0.0% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $37.2K | 645,800 | 0.0% |
| Kadmon Hldgs Inc(KDMN) | COM | 48283N106 | $32.9K | 6,426,700 | 0.0% |
| Principia Biopharma Inc(PRNB) | COM | 74257L108 | $32.8K | 548,500 | 0.0% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $32.4K | 674,487 | 0.0% |
| Horizon Therapeutics PUB LTD | SHS | G46188101 | $29.8K | 536,200 | 0.0% |
| Esperion Therapeutics Inc NE(ESPR) | COM | 29664W105 | $28.7K | 559,700 | 0.0% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $25.4K | 620,600 | 0.0% |
| Mersana Therapeutics Inc | COM | 59045L106 | $25.0K | 1,069,600 | 0.0% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $23.7K | 2,674,154 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $22.6K | 1,527,400 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $22.6K | 185,100 | 0.0% |
| Syneos Health Inc(8IN) | CL A | 87166B102 | $21.3K | 366,500 | 0.0% |
| Bristol-Myers Squibb Co(BMY-R) | RIGHT 99/99/9999 | 110122157 | $20.7K | 5,786,941 | 0.0% |
| Bioxcel Therapeutics Inc(BTAIEUR) | COM | 09075P105 | $20.6K | 388,095 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $20.3K | 738,547 | 0.0% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $20.2K | 274,300 | 0.0% |
| Harpoon Therapeutics Inc | COM | 41358P106 | $20.0K | 1,206,351 | 0.0% |
| Mckesson Corp(MCK) | COM | 58155Q103 | $19.6K | 128,000 | 0.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $18.9K | 1,331,100 | 0.0% |
| Editas Medicine Inc(EDIT) | COM | 28106W103 | $17.7K | 600,000 | 0.0% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $17.2K | 325,990 | 0.0% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $15.9K | 173,700 | 0.0% |
| Prevail Therapeutics Inc | COM | 74140Y101 | $15.3K | 1,028,800 | 0.0% |
| Royalty Pharma PLC(RPRX) | SHS CL A | G7709Q104 | $9.7K | 200,000 | 0.0% |
| Surface Oncology Inc | COM | 86877M209 | $9.7K | 1,478,699 | 0.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $9.3K | 156,266 | 0.0% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $8.8K | 418,178 | 0.0% |
| Verastem Inc | COM | 92337C104 | $7.6K | 4,414,991 | 0.0% |
| 1Life Healthcare Inc | COM | 68269G107 | $7.3K | 200,000 | 0.0% |
| Akouos Inc | COM | 00973J101 | $7.1K | 315,000 | 0.0% |